Koers HST Global, Inc. Other OTC
Aandelen
HSTC
US40432E2028
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 3,19 mln. 2,97 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | - |
Nettoschuld 2022 | 75,89K 70,79K | Nettoschuld 2023 | 96,79K 90,29K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-4,34
x | K/w-verhouding 2023 |
-21,8
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 37,71% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ron Howell
CEO | Chief Executive Officer | 75 | 08-05-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ron Howell
CEO | Chief Executive Officer | 75 | 08-05-08 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,77% | 42,86 mld. | |
+44,64% | 41,36 mld. | |
+12,24% | 42,74 mld. | |
-8,83% | 27,68 mld. | |
+7,44% | 25,15 mld. | |
-23,01% | 18,63 mld. | |
+30,56% | 12,37 mld. | |
-1,82% | 11,92 mld. | |
+8,35% | 11,21 mld. |